PMID: 9192553Jan 1, 1997Paper

Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis

Oral Oncology
S T SonisJ D Haley

Abstract

Mucositis is a common, dose-limiting complication in patients receiving cancer chemotherapy, which derives from damage to the epithelial cell layer. We have shown that transforming growth factor-beta 3 (TGF-beta 3) negatively regulates epithelial cell proliferation and reduces the incidence of oral mucositis. Here, we report the findings of a large study examining the effects of TGF-beta 3 administration in a hamster model on oral epithelial cell cycling in vivo, on oral mucositis, on weight retention and on survival. Topical application of TGF-beta 3 to the buccal mucosa significantly reduced basal cell proliferation, as measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and DNA ploidy. Administration of topical TGF-beta 3 prior to chemotherapy with 5-fluorouracil (5-FU) significantly reduced the severity of mucositis with respect to time, reduced chemotherapy-associated weight loss and increased survival.

Citations

Apr 28, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K K F ChengM P Yuen
Sep 19, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Judith E Raber-DurlacherUNKNOWN Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (
Jan 3, 2003·Oral Oncology·Andrei Barasch, Douglas E Peterson
Apr 11, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rachel J Gibson, Dorothy M K Keefe
Apr 29, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Vanessa C S PavesiManoela D Martins
Jul 5, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Brian D HodgsonHarry T Whelan
Jan 5, 2002·European Journal of Oral Sciences·M A WettergreenG R Adami
Nov 18, 2003·Alimentary Pharmacology & Therapeutics·M Duncan, G Grant
Oct 20, 2010·The Journal of Pathology·Erik Meulmeester, Peter Ten Dijke
Feb 13, 2015·Frontiers in Immunology·Abdulraouf Ramadan, Sophie Paczesny
May 13, 2014·Mediators of Inflammation·T M HavermanF R Rozema
Feb 23, 1999·The American Journal of Pathology·G A BjarnasonR B Sothern
Dec 3, 2004·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·S S PrimeI C Paterson
Jun 12, 2013·Brazilian Oral Research·Talita Christine Camilo LopezMárcia Martins Marques
Sep 14, 2011·Dermatologic Therapy·Andrei Barasch, Joel B Epstein
Feb 22, 2012·Biochemistry. Biokhimii︠a︡·V L Katanaev, M V Kryuchkov
Mar 30, 2019·Current Opinion in Supportive and Palliative Care·Hannah R WardillAndrea M Stringer
Aug 4, 2020·Journal of Pharmacy & Bioallied Sciences·Anmar Al-TaieAtaa Altaee
Sep 22, 2001·Journal of Immunotherapy·M C FoncubertaUNKNOWN Investigators in TGF-beta3/OM Study Protocols 203/205
Feb 1, 2020·Tissue Engineering and Regenerative Medicine·Harry JungHae Sang Park
Nov 6, 2001·Journal of the National Cancer Institute. Monographs·V H Lee
Oct 19, 2006·European Journal of Pharmacology·Hiromi MitsuhashiHiroaki Araki
Jun 25, 2009·European Journal of Pharmacology·Shinichi WatanabeHiroaki Araki
Jan 27, 2004·The American Journal of Pathology·Frédéric O MorvanJean-Louis Saffar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.